Clinical trials
Recruiting Carcinoma, Hepatocellular trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2017 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 1 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| Daiichi Sankyo | 1 |
| Fore Biotherapeutics | 1 |
| Leiden University Medical Center | 1 |
| Maastricht University | 1 |
| Maastricht University Medical Center | 1 |
| Mark C Burgmans, MD PhD | 1 |
| Newcastle University | 1 |
| Niek Wijnen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 13 |
| Liver Neoplasms | 4 |
| Cholangiocarcinoma | 3 |
| Biliary Tract Neoplasms | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Endometrial Neoplasms | 2 |
| Fibrosis | 2 |
| Neoplasm Metastasis | 2 |
| Non-alcoholic Fatty Liver Disease | 2 |
| Ovarian Neoplasms | 2 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.